Gynae BT 2017

GOG-122

N=396, stage III-IV(residual) Chemotherapy (doxorubicin-cisplatin x8) vs whole abdominal RT (WAI) Adjusted 5-yr OS: 53 vs 42% for chemo vs WAI Event rates similar: 54 vs 50% Substantial toxicity in chemotherapy arm Salvage by RT?

Progression-free Survival

Overall Survival

Randall et al, JCO 2006